# EyePoint (EYPT) — Overview

EYPT · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/eypt

## Price

Last close $3.12 on Oct 15, 2026. 52-week range $3.01 – $18.85.

## Company profile

EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care. The company's pipeline program includes i) DURAVYU: a sustained-release product candidate for retinal diseases, with the potential to provide patients with improved visual outcomes with less burden. ii) EYP-2301: early-stage program using Durasert E technology to deliver razuprotafib, a TIE-2 agonist targeting VE-PTP for vascular stability in retinal diseases like wet AMD.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $2.8M |
| Revenue (quarter) | $507,000.00 |
| Revenue growth (year over year) | -90.49% |
| Gross profit (trailing twelve months) | $1.2M |
| Gross margin | 41.57% |
| Net income (trailing twelve months) | −$306.6M |
| Net income (quarter) | −$94.5M |
| Net income growth (year over year) | -58.97% |
| Net margin | -10998.67% |
| Return on equity | -148.70% |
| EPS (trailing twelve months) | −$3.75 |
| Book value per share | $1.96 |
| P/E (trailing twelve months) | — |
| Price to book | 1.6 |
| Debt to assets | 27.07% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is EyePoint (EYPT) profitable?

No. EyePoint reported a net loss of $306.6M over the trailing twelve months.

### How much revenue does EyePoint (EYPT) make?

EyePoint generated $2.8M in revenue over the trailing twelve months, down 90.49% year over year.

### How do I buy stock in EyePoint (EYPT)?

EYPT trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).